Clinical Trial: 1 Year Canakinumab Treatment in Behcet's Disease Patients With Neurologic or Vascular Involvement

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: An Open Label, Exploratory Study to Establish the Efficacy and Safety of 1 Year Canakinumab Treatment in Behcet's Disease Patients With Neurologic or Vascular Involvement

Brief Summary: Primary objective of the study is to evaluate the safety and efficacy of canakinumab on the clinical and inflammatory findings of Behced Disease patients with neurologic and vascular involvement.